Matthew Vincent Dolan - Mar 4, 2022 Form 3 Insider Report for DEXCOM INC (DXCM)

Role
Officer
Signature
Jereme M. Sylvain
Stock symbol
DXCM
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
3
Date filed
3/10/2022, 04:39 PM
Next filing
Mar 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DXCM Common Stock 7.55K Mar 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Included in this number are 7,501 unvested restricted stock units, 1,034 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Remarks:

*SVP, Corporate Strategy/Development & New Markets